First Biosimilar Drug Set to Enter US Market

Nature - United Kingdom
doi 10.1038/517253a
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

An Overview of the Biosimilar Market in the Us

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

FDA Approves First Biosimilar to Treat Cancer

Cancer Discovery
Oncology
2017English

US Food and Drug Administration Disruption of Generic Drug Market Increases Hospital Costs

Anesthesia and Analgesia
AnesthesiologyPain Medicine
2018English

Exploring and Analyzing (Go) Decision for Burger Makers to Enter Singaporean Market

International Journal of Academic Research in Business and Social Sciences
2019English

How Can a Place Enter Our Skin Down to the Very Verb of Us

Sens public
2017English

Php217 - Time to Market and Price Comparison for Biosimilar Drugs in Eu5

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Php316 - Exploring Biosimilar Market Access Considerations Across the Eu

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

US Science Agencies Set to Win Big in Budget Deal

Nature
Multidisciplinary
2018English

Pcp67 - Regulatory Requirements and Scientific Rationale for Biosimilar: Us vs. European Union.

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy